Cargando…
Design and rationale of a randomised controlled trial comparing apixaban to phenprocoumon in patients with atrial fibrillation on chronic haemodialysis: the AXADIA-AFNET 8 study
INTRODUCTION: Patients with end-stage kidney disease requiring maintenance haemodialysis treatment experience a dramatic cardiovascular morbidity and mortality. Due to the high atherosclerotic and arteriosclerotic burden and profound alterations in haemostasis, they frequently suffer and die from bo...
Autores principales: | Reinecke, Holger, Jürgensmeyer, Sabine, Engelbertz, Christiane, Gerss, Joachim, Kirchhof, Paulus, Breithardt, Günter, Bauersachs, Rupert, Wanner, Christoph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6144324/ https://www.ncbi.nlm.nih.gov/pubmed/30206088 http://dx.doi.org/10.1136/bmjopen-2018-022690 |
Ejemplares similares
-
A Randomized Controlled Trial Comparing Apixaban With the Vitamin K Antagonist Phenprocoumon in Patients on Chronic Hemodialysis: The AXADIA-AFNET 8 Study
por: Reinecke, Holger, et al.
Publicado: (2022) -
Effects of electrical muscle stimulation in frail elderly patients during haemodialysis (DIAL): rationale and protocol for a crossover randomised controlled trial
por: Suzuki, Yuta, et al.
Publicado: (2019) -
Use of vitamin K antagonists for secondary stroke prevention depends on the treating healthcare provider in Germany – results from the German AFNET registry
por: Haeusler, Karl Georg, et al.
Publicado: (2015) -
Tunnelled haemodialysis catheter and haemodialysis outcomes: a retrospective cohort study in Zagreb, Croatia
por: Pašara, Vedran, et al.
Publicado: (2016) -
Attaining sinus rhythm mediates improved outcome with early rhythm control therapy of atrial fibrillation: the EAST-AFNET 4 trial( )
por: Eckardt, Lars, et al.
Publicado: (2022)